ProLungdx is a developer and provider of non-imaging and invasive diagnostics for lung cancer... Read more
ProLungdx is a developer and provider of non-imaging and invasive diagnostics for lung cancer... Read more
Est. Annual Revenue
<$1M
Est. Employees
<10
News
May 12, 2017
BioSpace
ProLung: ProLung Announces Closing Of Private Placement Transaction With Proceeds Of $8.2 Million
May 04, 2017
Blackbird
Press Release: ProLung : ProLung Selected to Participate at Upcoming Cavendish Global Health Impact Forum
Mar 08, 2017
BioPortfolio
ProLung: Fresh Medical Laboratories Inc Medical Equipment Deals and Alliances Profile Updated 23012017 Prices from USD $250
Feb 17, 2017
PharmiWeb
ProLung: ProLung Announces the Appointment of Dr. Robin L. Smith to its Board of Directors
Oct 14, 2016
Medical Devices Business Review
ProLung: ProLungdx unveils EPN Scan at BIO Investor Forum
Sep 06, 2016
PR Urgent
Press Release: ProLung : ProLungdx Showcases its EPN Scan® for Lung Cancer at the White Hat Investors Conference
Jun 01, 2016
Equities
ProLung: ProLungdx Board Names Dr. John C. Ruckdeschel as Newest Board Member
May 24, 2016
BioSpace
ProLung: <b>ProLungdx</b> Board Names <b>Dr. John C. Ruckdeschel</b> As Newest Board Member
May 19, 2016
Equities
ProLung: ProLungdx Announces Todd Morgan as Chairman of the Board
May 19, 2016
Business Wire
Press Release: ProLung : ProLungdx EPN Scan Confirms Performance in Early Lung Cancer Risk Assessment